SEC Form 4 · accession 0001209191-18-005099
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William F Doyle
Officer — Executive Chairman · Director
Period of report
Jan 22, 2018
Accepted (ET)
Jan 24, 2018 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jan 22, 2018 | M | 1,549 | $3.59 | A | 92,746 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantsF1 | $3.59 | Jan 22, 2018 | M | 1,549 | D | — | Jan 22, 2018 | Ordinary Shares | 1,549 | 0 | D |
Explanation of responses
- F1Exercisable at any time through January 22, 2018